Compensatory response to reducing body weight

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 3, 2005, Pages 313-319

  MacLean, Paul S ^a   Jackman, Matthew R ^a   Bessesen, Daniel H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,4 BENZODIOXAN 2 CARBOXYLIC ACID; AC 162352; AMG 076; ANTIOBESITY AGENT; APD 356; C 75; CP 640186; GHRELIN; INSULIN; KB 2115; LEPTIN; PEPTIDE YY; PHENTERMINE; PRAMLINTIDE; RECOMBINANT LEPTIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ADAPTATION; BODY WEIGHT; CLINICAL TRIAL; DIET RESTRICTION; DRUG MECHANISM; EATING HABIT; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; HOMEOSTASIS AND REGULATION; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LIFESTYLE; LIPID ABSORPTION; LIPID STORAGE; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRESCRIPTION; REVIEW; SATIETY; STOMACH DISEASE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33645078642     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.08.005     Document Type: Review

References (25)

1. J.E. Manson et. al. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians Arch. Intern. Med. 164 2004 249-258
2. M.L. Dansinger et. al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial J. Am. Med. Assoc. 293 2005 43-53
3. A. Tremblay E. Doucet Obesity: A disease or a biological adaptation? Obes. Rev. 1 2000 27-35
4. B.E. Levin The drive to regain is mainly in the brain Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 2004 R1297-R1300
5. P.S. MacLean A peripheral perspective of weight regain Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 2005 1447-1449
6. S.C. Woods et. al. Clinical endocrinology and metabolism. Regulation of energy homeostasis by peripheral signals Best Pract. Res. Clin. Endocrinol. Metab. 18 2004 497-515
7. P.S. MacLean et. al. Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 2004 R1306-R1315
8. A.G. Dulloo et. al. Pathways from weight fluctuations to metabolic diseases: Focus on maladaptive thermogenesis during catch-up fat Int. J. Obes. Relat. Metab. Disord. 26 Suppl. 2 2002 S46-S57
9. P. Nestel Nutritional aspects in the causation and management of the metabolic syndrome Endocrinol. Metab. Clin. North Am. 33 2004 483-492
10. D.E. Kelley L.J. Mandarino Fuel selection in human skeletal muscle in insulin resistance: A reexamination Diabetes 49 2000 677-683
11. L. Storlien et. al. Metabolic flexibility Proc. Nutr. Soc. 63 2004 363-368
12. P. Cettour-Rose et. al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: A link between catch-up growth and later metabolic syndrome Diabetes 54 2005 751-756
13. V. Fonseca Effect of thiazolidinediones on body weight in patients with diabetes mellitus Am. J. Med. 115 Suppl. 8A 2003 42S-48S
14. Y. Shi P. Burn Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity Nat. Rev. Drug Discov. 3 2004 695-710
15. H.E. Bays Current and investigational antiobesity agents and obesity therapeutic treatment targets Obes. Res. 12 2004 1197-1211
16. D.M. Muoio G. Lynis Dohm Peripheral metabolic actions of leptin Best Pract. Res. Clin. Endocrinol. Metab. 16 2002 653-666
17. M. Rosenbaum et. al. Effects of weight change on plasma leptin concentrations and energy expenditure J. Clin. Endocrinol. Metab. 82 1997 3647-3654
18. D. Infanger et. al. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects Obes. Surg. 13 2003 879-888
19. Y. Linne S. Rossner Pharmacotherapy of obesity Clin. Dermatol. 22 2004 319-324
20. S. Klein Long-term pharmacotherapy for obesity Obes. Res. 12 Suppl. 2004 163S-166S
21. C.M. Arbeeny Addressing the unmet medical need for safe and effective weight loss therapies Obes. Res. 12 2004 1191-1196
22. M. Weintraub et. al. Long-term weight control study. VI. Individual participant response patterns Clin. Pharmacol. Ther. 51 1992 619-633
23. R.J. Jandacek S.C. Woods Pharmaceutical approaches to the treatment of obesity Drug Discov. Today 9 2004 874-880
24. L. Seman et. al. Obesity: A chronic disease in need of drug targets and safe medicines Discov. Med. 5 2005 94-103
25. K. Elfhag S. Rossner Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain Obes. Rev. 6 2005 67-85